Advanced imaging pinpoints prostate cancer faster, more accurately

October 5, 2012

It took Wayne Wentzel 14 years, multiple tissue biopsies and travel to four hospitals across multiple states to identify the underlying source of his rising prostate specific antigen (PSA) level. He finally found answers at the University of Cincinnati Cancer Institute.

PSA is calculated based by blood test and used to identify potential signs of prostate cancer. Other issues can contribute to rising PSA—such as enlarged prostate and infection—but the test is the medical community's No. 1 tool for

On a mission to find answers, Wentzel's son-in-law—a Georgia radiologist—found Cincinnati-based radiologist Sadhna Verma, MD. She leads an innovative prostate imaging program based at UC Health University Hospital that utilizes both and 3T spectroscopy imaging to more accurately diagnose prostate cancer before invasive measures are taken. 

"MR imaging has shown to improve detection and accuracy of staging of prostate cancer in patients with prostate cancer," says Verma, a UC associate professor of radiology and UC Health radiologist. "Adding functional sequences gives us biochemical clues in addition to anatomic data to help us pinpoint cancers in the prostate gland that often go undetected otherwise."    

Wentzel, a 69-year-old retired pastor from Michigan, began experiencing a rising PSA in 1998. Before arriving in Cincinnati, he had undergone eight that resulted in the removal of 52 tissue samples —all were negative for cancer.

"The biopsies were painful and got me nowhere. The 3T multi-parametric prostate MRI with scans at UC came back to show a mass in my prostate immediately. Following this, I had an MRI-guided biopsy that confirmed 7 prostate cancer," recalls Wentzel.

He traveled back home to Ann Arbor, Mich., to undergo robotic closer to home in August 2012. 

"I can finally focus on enjoying my retirement without worrying about that rising PSA. I exercise daily to keep my energy up and take the boat out any opportunity I get," he says. 

About the Prostate Imaging Program 
In partnership with UC Health, the UC Cancer Institute offers comprehensive evaluation of the prostate gland that provided both anatomic and biochemical information about the gland.

"Prostate cancer treatment is determined primarily by the stage of disease and whether cancer is confined within the prostate capsule or has extended beyond the prostate gland," explains Verma, who is part of the multidisciplinary genitourinary cancer team at the UC Cancer Institute. "Men have several choices when it comes to treatment. Accuracy of staging is critical for choosing the approach that is right for each individual." 

Explore further: When rising PSA means prostate cancer is in patient's future

More information: Prostate imaging services: www.med.uc.edu/radiology/resea … 20Program/Index.html

Related Stories

When rising PSA means prostate cancer is in patient's future

May 18, 2011
A man's rising PSA (prostate-specific antigen) level over several years – which had been seen as a possible warning sign of prostate cancer – has recently come under fire as a screening test because it sometimes ...

PSA test valuable in predicting biopsy need, low-risk prostate cancer

October 21, 2011
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. ...

New prostate cancer test gives more accurate diagnosis

April 6, 2011
In a large multi-center clinical trial, a new PSA test to screen for prostate cancer more accurately identified men with prostate cancer -- particularly the aggressive form of the disease -- and substantially reduced false ...

New imaging agent has an appetite for dangerous prostate tumors

December 8, 2011
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a ...

Cancer biomarker -- detectable by blood test -- could improve prostate cancer detection

August 8, 2011
A new study supports the use of a DNA-based "biomarker" blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer. University of Cincinnati (UC) researchers ...

Genetic test may reduce need for repeat biopsy for prostate cancer

July 18, 2012
Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man’s ...

Recommended for you

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

Skewing the aim of targeted cancer therapies

August 15, 2017
Headlines, of late, have touted the successes of targeted gene-based cancer therapies, such as immunotherapies, but, unfortunately, also their failures.

Findings pave way for three-drug combination treatment for childhood leukemia

August 15, 2017
UCLA researchers have developed a new approach that could eventually help young people respond better to treatment for acute lymphoblastic leukemia. The scientists discovered in mice that when the production of nucleotides—also ...

Does stronger initial response to cancer treatment predict longer overall survival?

August 15, 2017
It seems like such a simple question: Do patients whose tumors shrink more in response to targeted treatment go on to have better outcomes than patients whose tumors shrink less? Actually, the answer seems simple too. In ...

New study reveals late spread of breast cancer and backs key role of early diagnosis

August 14, 2017
Breast cancer cells that spread to other parts of the body break off and leave the primary tumour at late stages of disease development, scientists from the Wellcome Trust Sanger Institute and their collaborators have found.

Discovery of new prostate cancer biomarkers could improve precision therapy

August 14, 2017
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine. In the publication, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterD
1 / 5 (1) Oct 05, 2012
Anyone who thinks a PSA test means anything is an idiot.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.